Antimutagenic effects of radioprotector WR-2721 against fission-spectrum neurons and 60Co gamma-rays in mice.
The antimutagenic effects of the radiation protective agent, S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721), were studied against fission-spectrum-neutron- and 60Co-gamma-ray-induced mutagenesis in mice. Mutagenesis at the hypoxanthine-guanine phosphoribosyl transferase (hprt) locus was measured 56 days following whole-body irradiation with JANUS neutrons (single doses, 50-150 cGy) or 60Co photons (single doses, 250-750 cGy). Splenic T lymphocytes from B6CF1 mice were grown in round-bottomed 96-microwell culture plates with or without the selective agent 6-thioguanine (6-TG). The mutant frequency, as a result of exposure to neutrons or 60Co photons, increased 100-fold with dose. Doses of 150 cGy neutrons and 750 cGy 60Co photons were equally mutagenic. When animals were injected with WR-2721 at a dose of 400 mg/kg body weight, i.p., 30 min before whole-body irradiation with JANUS neutrons or 60Co photons, mutant frequencies were significantly reduced at all radiation doses (i.e. protection factors of 1.4 and 2.4, respectively). Thus, the aminothiols are effective antimutagens. A novel clinical application of these compounds could be in their use to protect against radiation- and/or chemotherapy-induced genotoxic damage to normal cells.
Biological and Medical Research Division, Argonne National Laboratory, IL 60439-4833.
Y
Y
Kataoka
I
I
Basic
J
J
Perrin
D J
DJ
Grdina
D004999:Amifostine / Q000627:therapeutic use*; D000818:Animals; D016587:Antimutagenic Agents / Q000627:therapeutic use*; D003037:Cobalt Radioisotopes; D005720:Gamma Rays; D008297:Male; D051379:Mice; D009502:Neutrons; D011831:Radiation Genetics; D011837:Radiation-Protective Agents / Q000627:therapeutic use*
D016587:Antimutagenic Agents; D003037:Cobalt Radioisotopes; D011837:Radiation-Protective Agents; D004999:Amifostine